On Tuesday, Indian equities extended gains for a fourth straight day, with the Nifty 50 closing above the 23,100 level. (Pixabay)AI Quick ReadStock market today: Indian benchmark indices, Sensex and Nifty 50, are expected to start Wednesday’s session on a positive note, tracking a global market rally triggered by the announcement of a ceasefire agreement between the US and Iran.
Indicators from Gift Nifty also suggest a gap-up opening for domestic markets, with the index trading near the 23,840 mark—about 689 points above the previous close of Nifty futures.
“Indian markets are set for a strong gap-up opening, with Gift Nifty rebounding sharply to the 23,800 zone after a weak overnight trend. The shift reflects a decisive improvement in global risk sentiment following a temporary de-escalation in West Asia tensions. Volatility is likely to ease in today’s session. India VIX, which closed near 24.7, may see further cooling as fear unwinds, leading to some moderation in option premiums and improved trading conditions,” said Hariprasad K, SEBI-registered Research Analyst and Founder, Livelong Wealth.
On Tuesday, Indian equities extended gains for a fourth straight day, with the Nifty 50 closing above the 23,100 level. The Sensex rose 509.73 points, or 0.69%, to end at 74,616.58, while the Nifty 50 advanced 155.40 points, or 0.68%, to settle at 23,123.65.
Amid the backdrop of the US-Iran war ceasefire deal, these stocks are likely to remain in focus on Wednesday, April 8, 2026 —
The IT company has unveiled a strategic partnership with Harness, an AI-powered software delivery platform, aimed at speeding up agentic AI-driven transformation in software delivery for enterprises worldwide.
Ola Electric on Tuesday announced that its indigenously developed lithium iron phosphate (LFP) cell is now ready, marking a significant milestone in its effort to accelerate electric mobility and establish a fully integrated energy ecosystem.
The company has fixed April 13, 2026, as the record date to identify shareholders eligible to receive the interim dividend for FY26, pending approval from the board.
According to a regulatory filing, based on the declaration submitted by Jha, he is not disqualified from holding the position of Director under any order issued by SEBI or any other authority.
The Competition Commission of India has cleared an investment of about ₹2,750 crore in the company’s subsidiary, Aditya Birla Housing Finance, to be made by Indriya, an entity affiliated with Advent International.
Aurobindo Pharma has secured approval from the US Food and Drug Administration for its Dapagliflozin & Metformin Hydrochloride extended-release tablets. These tablets are prescribed to help manage blood sugar levels in adults with Type 2 Diabetes.
The company on Tuesday reported a tax demand of ₹327.44 crore for the assessment year 2022–23, attributing it to a technical error in an order issued by the Income Tax Department’s Assessment Unit.
The company has secured a fresh order valued between ₹1,500 crore and ₹3,000 crore from Energy ONE to build four dual-fuel ammonia bulk carriers, each with a capacity of 92,500 DWT.
The global biopharmaceutical firm has announced the commercial rollout of Bosaya (denosumab-kyqq) and Aukelso (denosumab-kyqq) in the United States.
The company announced that it has commissioned a 185 MW wind-solar hybrid project in Kalavad, Gujarat, as the renewable energy firm continues to expand its portfolio in one of India’s major industrial states.
Disclaimer: This story is for educational purposes only. Please consult with an investment advisor before making any investment decisions.
Vaamanaa covers business and stock market news. Started in 2020, she has been producing news on digital platforms for over 4.5 years now. She writes on markets, commodities, IPOs, and industry. She has worked for news channels like Jagran New Media and Business Insider India. You can reach out to her at vaamanaa.sethi@htdigital.in.